ITPR2 and breast carcinoma: For instance, a subset of tumor tissue samples derived from breast cancer patients express higher IP3R2/IP3R3 levels compared to the adjacent non-tumorigenic tissue, which has been related to subsequent alterations in metabolic products (123, 124).